Super Human Blend Peptide

Comprehensive multi-peptide research stack designed for broad-spectrum regeneration research. Combines tissue repair (BPC-157/TB-500 type), neuroprotection, immune modulation, and GH axis compounds in a single formulation for holistic regeneration studies.

The Super Human Blend is a research-oriented multi-peptide stack designed to investigate convergent biological pathways involved in tissue homeostasis, neuroplasticity, immune signaling, and somatotropic axis activation. Because the blend combines compounds with distinct molecular targets, its mechanistic profile is best understood as a network of parallel signaling cascades rather than a single receptor-ligand interaction. Researchers studying this blend typically evaluate how simultaneous activation of multiple regenerative pathways modulates outcomes that single-compound administration cannot fully recapitulate.

Tissue Repair Pathway (BPC-157 / TB-500 component class)

Body Protection Compound-15 and Thymosin Beta-4 fragments converge on cytoskeletal remodeling and angiogenesis. BPC-157 has been associated with upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) and activation of the nitric oxide (NO) pathway, while TB-500 binds G-actin monomers to facilitate actin polymerization, accelerating cell migration into wound beds [1]. In preclinical models these mechanisms have been associated with enhanced fibroblast recruitment, capillary sprouting, and extracellular matrix reorganization.

Growth Hormone Axis (GHRP / GHRH component class)

Growth hormone secretagogues such as Ipamorelin act on the ghrelin receptor (GHS-R1a) on pituitary somatotrophs, while GHRH analogs such as CJC-1295 bind the GHRH receptor (GHRHR). Co-activation produces a synergistic, pulsatile release of endogenous growth hormone, which downstream raises hepatic IGF-1 secretion via JAK2/STAT5 signaling. Research suggests this dual-receptor approach preserves the physiological pulsatility lost with exogenous GH administration.

Neuroprotective Signaling

Heptapeptide neuromodulators in the blend interact with BDNF expression, dopaminergic tone, and HPA axis regulation. Selank-class peptides modulate GABAergic transmission and enkephalin degradation, while Semax-class peptides upregulate BDNF and NGF in hippocampal and cortical tissue in rodent models [2].

Immune Modulation

Thymic-derived peptide components engage Toll-like receptors (TLR2/TLR9) on dendritic cells, shifting cytokine profiles toward Th1 responses and enhancing CD4+/CD8+ maturation. This arm of the blend is studied for its role in restoring immune competence in models of immunosenescence.

Convergent Downstream Effects

Although each component class has a distinct primary receptor, downstream second messengers (cAMP, PI3K/Akt, MAPK/ERK) overlap substantially. Research using multi-pathway stacks is designed to investigate whether simultaneous low-dose modulation produces additive or synergistic effects on systemic regeneration markers (IGF-1, hydroxyproline, BDNF, IL-10) compared with single-agent protocols. Investigators should note that the pharmacokinetic profiles of individual components differ markedly, requiring careful study design when interpreting blended outcomes.

The Super Human Blend is a proprietary multi-peptide research formulation. Because it contains multiple distinct molecular entities, it does not have a single molecular formula, molecular weight, or CAS number. Each component peptide is supplied at research-grade purity (≥98% HPLC where applicable) and combined in lyophilized form for reconstitution. The table below documents representative component classes and their verified individual specifications, where the component is a defined single molecule. Investigators should refer to the certificate of analysis (COA) accompanying each lot for exact component ratios.

Note on blend composition: The exact component selection in any Super Human Blend lot is documented on the lot-specific COA. Component selection may be customized for specific research protocols. Researchers reproducing studies should reference the COA component manifest rather than assuming a fixed formulation across lots.

Because the Super Human Blend contains multiple peptides with differing stability profiles, careful reconstitution and handling are essential to preserve component integrity. The following protocol is recommended for research use only.

Reconstitution Protocol

1. Equilibrate vials to room temperature (15-20 minutes) before opening to prevent condensation on the lyophilized powder.
2. Sanitize the rubber septum of the blend vial and the bacteriostatic water vial with 70% isopropyl alcohol.
3. Draw diluent: Using a sterile syringe, withdraw the desired volume of bacteriostatic water (0.9% benzyl alcohol). A typical reconstitution is 2 mL of BAC water per 10 mg total peptide mass.
4. Inject slowly: Angle the needle so diluent runs down the inner wall of the vial onto the powder, rather than dispensing directly onto the lyophilized cake.
5. Dissolve gently: Swirl the vial in a slow circular motion until fully dissolved. Do not shake or vortex — mechanical agitation can shear peptide bonds and denature components such as Thymosin Alpha-1.
6. Inspect: The reconstituted solution should be clear and colorless. Any cloudiness or precipitate indicates improper reconstitution or component degradation.

Concentration Calculation

Total peptide concentration is calculated against the combined component mass. For a blend containing 10 mg total peptide reconstituted in 2 mL BAC water, the concentration is 5 mg/mL of combined peptides. Individual component concentrations depend on the lot-specific ratio documented on the COA.

Compound-Specific Handling Notes

• Methionine-containing components (e.g., Semax, Selank) are susceptible to oxidation — minimize air exposure and store reconstituted solution under refrigeration.
• Thymic peptide components are heat-labile; avoid temperatures above 25°C even briefly.
• GHRH analog components can adsorb to glass — siliconized vials or polypropylene aliquot tubes are recommended for long-term storage of reconstituted material.
• Aliquot reconstituted blend into single-use volumes to minimize freeze-thaw cycles, which disproportionately degrade the most labile components.

All handling should be performed in a laminar flow hood or equivalent sterile environment. Reconstituted blends should be labeled with date, concentration, and component manifest reference.

Multi-peptide blends present unique storage considerations because each component peptide may have distinct stability profiles. The Super Human Blend should be stored under conditions that protect the least stable component, ensuring the integrity of all peptides in the formulation.

Lyophilized (Unreconstituted) Storage

• Long-term storage (greater than 30 days): Store at -20°C or colder in the original sealed vial. Under these conditions, lyophilized peptide blends typically maintain ≥95% potency for 24 months or longer.
• Short-term storage (less than 30 days): Refrigeration at 2-8°C is acceptable. Ensure the vial remains sealed to prevent moisture ingress.
• Transit/room temperature: Lyophilized peptides tolerate brief exposure (up to 7-14 days) to ambient temperatures (15-25°C) without significant degradation. This stability supports standard shipping protocols.

Reconstituted Storage

Once reconstituted with bacteriostatic water or sterile saline, peptide stability decreases substantially:

• 2-8°C refrigeration: Use within 14-21 days for blends containing more stable peptides; shorter intervals (7-10 days) for blends containing methionine-rich or disulfide-containing peptides.
• -20°C freezer storage: Reconstituted solutions can be stored for 30-60 days, but repeated freeze-thaw cycles should be avoided. Single-use aliquoting is recommended.
• Room temperature: Not recommended for reconstituted blends beyond the immediate working session.

Blend-Specific Stability Considerations

Several factors affect the stability of multi-peptide formulations:

• Methionine oxidation: Components containing methionine (Met) residues are susceptible to oxidation. Minimize air exposure during reconstitution and storage.
• Disulfide bond integrity: Peptides with intramolecular disulfide bonds may undergo scrambling under prolonged storage in solution.
• pH sensitivity: Bacteriostatic water typically buffers near neutral pH, which is generally optimal for peptide stability. Avoid acidic or strongly alkaline diluents.
• Light exposure: Some peptides exhibit photosensitivity. Amber vials or foil-wrapped storage is recommended for prolonged storage.

Signs of Degradation

Inspect reconstituted blends before each research use. Signs of degradation include visible cloudiness, particulate matter, color changes, or precipitation. Any solution showing these characteristics should be discarded. Lyophilized powder that has absorbed moisture (clumping, color change) should not be reconstituted.